Bio-asset rights & IP management | Biological Version Control | Accelerate R&D | Protect biological IP
GitLife Biotech is a pioneering force in biotechnology research, dedicated to revolutionizing the management and protection of biological intellectual property. At the forefront of synthetic biology, GitLife Biotech offers a robust bio-digital platform, CellRepo, designed to improve the identification and traceability of engineered biological assets. This innovative platform enhances intellectual property (IP) protection, provides proof of provenance, ensures secure collaboration, and improves traceability, effectively alleviating biosecurity concerns.
GitLife Biotech's CellRepo platform brings structure, traceability, and security to every stage of bio-innovation, from early research to commercialization. Acting as a version control system for biology, CellRepo offers barcoded, traceable cells that function as 'PDFs for your strains,' providing a clear and tamper-proof chain of custody for every asset. This enables instant proof of ownership, accelerating funding, licensing, and overall innovation. GitLife Biotech is located in Newcastle, GB and Cambridge, GB.
GitLife Biotech is committed to empowering scientists, R&D managers, and innovation leaders with the tools they need to thrive in today's fast-moving biotech environments. By seamlessly integrating into existing lab workflows, CellRepo ensures that groundbreaking research is protected and easily managed. We invite the manager of GitLife Biotech to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative solutions.
Other organizations in the same industry
This company is also known as